PeptideStack
5.2kquestions
20kanswers
220users

Is 2.5 mg/mL a sensible working concentration for mazdutide, or should I go lower?

Asked 6 Jul 2024Modified 21 months agoViewed 20k times
8

What I am working with: 2.5 mg/mL · mazdutide.

I suspect the honest answer is that it depends, in which case I would like to know on what.

Assume I can obtain either option without difficulty, so availability is not the deciding factor.

Is there a defensible reason to prefer one, or is this a coin flip?

diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

295 questions
reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

313 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
mazdutide
mazdutide

A GLP-1 and glucagon receptor dual agonist developed primarily in China, with a distinct dose range and a fast-moving publication record.…

237 questions
shareeditfollowflag
IB
askedilaria_bertone33k386 Jul 2024
7Same situation here, so I will follow this one. – Dr_Aoife_Brennan 4 months ago
6What syringe are you using? The answer is different for a 0.3 mL barrel and a 1 mL one. – jo_vandeberg 2 months ago
add a comment

5 Answers

Accepted answer first, then by votes
33

Accepted answer

At 2.5 mg/mL a 0.25 mg draw is 10 units on a U-100 barrel and a 2.4 mg draw is 96. Those two numbers decide it, because the concentration is only sensible relative to the smallest and largest volumes you will actually measure with it. Both land on a readable part of a U-100 barrel, which is the entire point of choosing the diluent volume deliberately rather than pouring in a round number. The other consideration is time: a vial you will finish in a fortnight can be concentrated, and a vial you will draw from for months should be split at reconstitution instead.

The relevant arithmetic is concentration equals vial content divided by diluent volume, and content is not the same as label claim.

The other direction: 10 mg in 3 mL is 3.33 mg/mL, and a 0.5 mg dose becomes 0.15 mL, or 15 units. More barrel, easier reading, and a larger fraction of the vial volume lost to dead space across the same number of draws.

Dead space by syringe type

ConfigurationDead volumeLoss at 5 mg/mLOver 20 draws
Fixed-needle insulin syringe3–5 µL15–25 µg0.3–0.5 mg
Low-dead-space, detachable<2 µL<10 µg<0.2 mg
Standard luer-lock + 30G35–60 µL175–300 µg3.5–6 mg
Luer-lock + 21G drawing needle70–100 µL350–500 µg7–10 mg

Mechanically, dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.

Published content assay results across the independent testing services show nominal and measured content differing by one to ten per cent, which makes content the dominant term in dose error.

Nothing here is medical advice, and research-use material is not approved for human use.

Measure a volume you can actually measure. Round numbers, real syringes.

edited 5 Oct 2024 by tabular_nums — clarified the distinction between purity and content

shareimprove this answerflag
TN
answered · acceptedtabular_nums71k482 Oct 2024
6Would this be different for a peptide that foams? Mine does and I have never known why. – tobias_maartens 36 days ago
add a comment
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
29

The honest answer is that a wide range of volumes works and that the extremes at either end cause avoidable problems.

Worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.

Round to a diluent volume you can measure accurately. Measuring 1.00 mL on a 1 mL syringe is reliable; measuring 1.37 mL on anything is not, and the error propagates into every dose.

The caveat is that this arithmetic assumes the vial contains what the label says, and without a content assay it is precise about an unknown quantity.

Concentration equals content over volume, and content is not label claim.

shareimprove this answerflag
M4
answeredmz_4113101k35821 Sept 2024
16

This is the one decision in the whole preparation sequence that cannot be revised later, which is why it is worth thirty seconds of arithmetic.

Vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.

Worth being precise here: for a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.

Nominal vial volumes in the standard 2R and 3R glass sizes have published brimful capacities well above the nominal fill, but the usable volume is bounded by the stopper displacement.

Do not change the diluent volume between vials of a titration without recalculating; it is the commonest source of a ten-fold error.

Write the concentration on the label at reconstitution, in units per dose.

shareimprove this answerflag
BB
answeredbac_or_bust33k13713 Oct 2024
4Thank you — this is the answer I was looking for. – kirsi_lahtinen 6 months ago
3Adding a vote because this deserves more of them. – tri_gly_ala 5 months ago
add a comment
13

Total vial volume is a physical constraint: most 2 mL vials will not take 3 mL of anything.

Write the concentration and the resulting units-per-dose on the vial label at reconstitution. The arithmetic that is obvious now will not be obvious at six in the morning three weeks from now.

Insulin syringe barrel graduations are typically 1 unit on a 0.3 mL barrel, 1 unit on a 0.5 mL barrel and 2 units on a 1 mL barrel, which is why the barrel size changes what is readable.

Choose the volume that puts your largest intended dose between 10 and 30 units. Everything else follows.

shareimprove this answerflag
TO
answeredt_oyelaran79k4824 Oct 2024
12

Start from the dose you intend to draw and work backwards to the volume that puts it in a readable part of the barrel.

Content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.

U-100 means 100 units per millilitre by definition, so 1 unit is 0.01 mL and volume in millilitres times one hundred gives units. Every conversion here reduces to that.

Check the vial can physically hold the volume before you draw it up.

shareimprove this answerflag
FC
answeredfiadh_cronin58k588 Aug 2024
2Does this change at lower concentrations, or does adsorption start to dominate? – marcus_thorbjorn 35 days ago
Confirming: I did the wrong thing here once and got exactly the predicted result. – sian_llewellyn 9 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.